These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 206110)

  • 1. Striato-cerebellar pathway controlling cyclic GMP content in the cerebellum: role of dopamine, GABA and enkephalins.
    Biggio G; Corda MG; Casu M; Gessa GL
    Adv Biochem Psychopharmacol; 1978; 18():227-44. PubMed ID: 206110
    [No Abstract]   [Full Text] [Related]  

  • 2. Different mechanisms mediating the decrease of cerebellar cGMP elicited by haloperidol and diazepam.
    Biggio G; Costa E; Guidotti A
    Adv Biochem Psychopharmacol; 1976; 15():325-35. PubMed ID: 192052
    [No Abstract]   [Full Text] [Related]  

  • 3. Kainic acid-induced lesion of dopaminergic target cells in the striatum: consequences on the dynamics of cerebellar cGMP.
    Biggio G; Corda MG; Casu M; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Aug; 304(1):5-7. PubMed ID: 211448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologically induced changes in the 3':5'-cyclic guanosine monophosphate content of rat cerebellar cortex: difference between apomorphine, haloperidol and harmaline.
    Biggio G; Costa E; Guidotti A
    J Pharmacol Exp Ther; 1977 Jan; 200(1):207-15. PubMed ID: 13199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for involvement of GABA in the action of benzodiazepines: studies on rat cerebellum.
    Costa E; Guidotti A; Mao CC
    Adv Biochem Psychopharmacol; 1975; (14):113-30. PubMed ID: 242198
    [No Abstract]   [Full Text] [Related]  

  • 6. Disappearance of cerebellar cyclic GMP induced by kainic acid.
    Biggio G; Corda MG; Casu M; Salis M; Gessa GL
    Brain Res; 1978 Oct; 154(1):203-8. PubMed ID: 212160
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system].
    Zharkovskiĭ AM; Nurk AM
    Fiziol Zh SSSR Im I M Sechenova; 1981 Nov; 67(11):1606-10. PubMed ID: 6799331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dopaminergic agonists and antagonists on in vivo cyclic nucleotide content: relation of guanosine 3':5'- monophosphate (cGMP) changes in cerebellum to behavior.
    Breese GR; Mueller RA; Mailman RB
    J Pharmacol Exp Ther; 1979 May; 209(2):262-70. PubMed ID: 35602
    [No Abstract]   [Full Text] [Related]  

  • 9. GABA-receptors in the substantia nigra controlling cyclic-GMP in the cerebellar cortex.
    Biggio G; Corda MG; Casu M; Mulas ML; Gessa GL
    Adv Exp Med Biol; 1979; 123():419-27. PubMed ID: 229716
    [No Abstract]   [Full Text] [Related]  

  • 10. Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systems.
    Bartholini G; Scatton B; Worms P; Zivkovic B; Lloyd KG
    Adv Biochem Psychopharmacol; 1981; 30():119-28. PubMed ID: 6120626
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes of rat cerebellar guanosine 3',5'-cyclic phosphate by dopaminergic mechanisms in vivo.
    Burkard WP; Pieri L; Haefely W
    Adv Biochem Psychopharmacol; 1976; 15():315-24. PubMed ID: 192051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intrastriatal glutamic acid injection on rat cerebellar cyclic GMP levels.
    Lautié JP; Kouyoumdjian JC; Haidamous M; Lacombe C; Grignon L; Gonnard P
    J Neurochem; 1981 Sep; 37(3):801-3. PubMed ID: 6115892
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dopaminergic regulation of the activity of peptidergic, GABAergic and glutamatergic neuronal systems in the striatum].
    Kerkerian L; Cupo A; Dusticier N; Epelbaum J; Errami M; Ettayebi K; Forni C; Jarry T; Kumar U; Salin P
    Encephale; 1989; 15 Spec No():143-54. PubMed ID: 2472955
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of cyclic GMP in cerebellum by a striatal dopaminergic mechanism.
    Biggio G; Guidotti A
    Nature; 1977 Jan; 265(5591):240-2. PubMed ID: 189208
    [No Abstract]   [Full Text] [Related]  

  • 15. Is the striato-nigral pathway responsible for 'feed-back' control of dopamine release [proceedings]?
    Arbuthnott GW; Garcia-Munoz M; Nicolaou NM; Tulloch IF; Wright AK
    Br J Pharmacol; 1976 Oct; 58(2):272P. PubMed ID: 974393
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of drugs which alter GABA-ergic function on cerebellar guanosine-3',5'-monophosphate content.
    Mailman RB; Mueller RA; Breese GR
    Life Sci; 1978 Aug; 23(6):623-7. PubMed ID: 211362
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of striatal dopamine receptors in the regulation of cerebellar cyclic GMP.
    Biggio G; Corda MG; Casu M; Gessa GL
    Ann Ist Super Sanita; 1978; 14(1):147-56. PubMed ID: 227304
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of 3', 5'-cyclic guanosine monophosphate content in deep cerebellar nuclei.
    Biggio G; Costa E; Guidotti A
    Neuroscience; 1977; 2(1):49-52. PubMed ID: 199855
    [No Abstract]   [Full Text] [Related]  

  • 19. Apomorphine stereotypies and transmitter mechanisms in the striatum. I. Changes in the apomorphine stereotypies caused by drugs acting on the GABA-ergic, dopaminergic and cholinergic transmission.
    Georgiev VP; Markovska VL; Petkova BP
    Acta Physiol Pharmacol Bulg; 1978; 4(3):56-64. PubMed ID: 220843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCK modulation of cerebellar afferents: dopaminergic involvement.
    Wood PL
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):513-8. PubMed ID: 2546180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.